Hossein Ansari is a Neurology physician affiliated with University of California San Diego. OpenAlex indexes 33 publications with 356 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
19 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
96.3%Neuromuscular Blocker96.2%Onabotulinumtoxina100%Part B, office-administered≥25 patientsgamma-Aminobutyric Acid-ergic Agonist0.1%Baclofen100%Part D<11 patientsNervous system
2.9%Gabapentinoids0.6%Gabapentin81%Pregabalin19%Part D<11 patientsSerotonin-1b and Serotonin-1d Receptor Agonist0.5%Naratriptan Hcl42%Sumatriptan Succinate37%Rizatriptan21%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
0.3%Serotonin-3 Receptor Antagonist0.2%Ondansetron Odt100%Part D≥11 patientsCorticosteroid0.1%Prednisone100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Qualitative validation of TnED©, an electronic instrument capturing pain dimensions in patients with trigeminal neuralgia
Journal of Oral & Facial Pain and Headache
2026 - Posttraumatic Headache: A Possible Therapeutic Target of Transcranial Magnetic Stimulation
Journal of Neuropsychiatry
2025 - Healthy eating index 2015 might be associated with migraine headaches: Results from a Case–Control study
Food Science & Nutrition
2024 - POST-TRAUMATIC HEADACHE (PTH): POSSIBLE NEW THERAPEUTIC TARGET FOR TRANSCRANIAL MAGNETIC STIMULATION?
Transcranial magnetic stimulation .
2024 - Bariatric surgery in migraine patients: CGRP level and weight loss
Journal of the Neurological Sciences
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Douglas Richman, MD
University of California San Diego
Irene Litvan, MD
University of California San Diego
Robert Weinreb, MD
University of California San Diego
Dilip Jeste, MD
University of California San Diego
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”